Article
Creation of de novo cryptic splicing for ALS/FTD precision medicine
2023-11-15
Abstract excerpt
A system enabling the expression of therapeutic proteins specifically in diseased cells would be transformative, providing greatly increased safety and the possibility of pre-emptive treatment. Here we describe “TDP-REG”, a precision medicine approach primarily for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), which exploits the cryptic splicing events that occur in cells with TDP-43 loss-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3b53c417-acb0-584d-a89f-f29f6c4e0453
- DOI
- 10.1101/2023.11.15.565967
